Labs that run molecular diagnostic tests are not only worried about getting short-changed on payment for the tests by some Medicare Part B contractors, but that the tests will not be covered at all.
“A growing concern to us I think, or of equal concern with the prices, is the coverage issue,” JoAnne Glisson,...